Aldeyra Therapeutics, Inc. (ALDX)
0.65
+0.03
(+4.74%)
USD |
NASDAQ |
Nov 04, 16:00
0.64
-0.01
(-1.54%)
After-Hours: 19:30
Aldeyra Therapeutics Market Cap : 39.21M for Nov. 4, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 03, 2026 | 37.44M |
| November 02, 2026 | 35.18M |
| October 30, 2026 | 33.80M |
| October 29, 2026 | 39.76M |
| October 28, 2026 | 41.24M |
| October 27, 2026 | 38.68M |
| October 26, 2026 | 38.71M |
| October 23, 2026 | 39.19M |
| October 22, 2026 | 38.93M |
| October 21, 2026 | 40.43M |
| October 20, 2026 | 44.29M |
| October 19, 2026 | 40.12M |
| October 16, 2026 | 42.23M |
| October 15, 2026 | 44.47M |
| October 14, 2026 | 47.68M |
| October 13, 2026 | 54.28M |
| October 12, 2026 | 54.64M |
| October 09, 2026 | 55.27M |
| October 08, 2026 | 57.17M |
| October 07, 2026 | 57.82M |
| October 06, 2026 | 55.25M |
| October 05, 2026 | 55.72M |
| October 02, 2026 | 70.58M |
| October 01, 2026 | 77.81M |
| September 30, 2026 | 74.20M |
| Date | Value |
|---|---|
| September 29, 2026 | 79.62M |
| September 28, 2026 | 69.97M |
| September 25, 2026 | 72.69M |
| September 24, 2026 | 73.59M |
| September 23, 2026 | 81.43M |
| September 22, 2026 | 84.15M |
| September 21, 2026 | 81.43M |
| September 18, 2026 | 82.04M |
| September 17, 2026 | 83.24M |
| September 16, 2026 | 82.64M |
| September 15, 2026 | 82.64M |
| September 14, 2026 | 88.07M |
| September 11, 2026 | 80.83M |
| September 10, 2026 | 88.07M |
| September 09, 2026 | 90.48M |
| September 08, 2026 | 92.89M |
| September 04, 2026 | 89.28M |
| September 03, 2026 | 89.28M |
| September 02, 2026 | 89.88M |
| September 01, 2026 | 89.88M |
| August 31, 2026 | 89.28M |
| August 28, 2026 | 89.58M |
| August 27, 2026 | 92.89M |
| August 26, 2026 | 94.10M |
| August 25, 2026 | 93.50M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Prime Medicine, Inc. | 897.36M |
| Arrowhead Pharmaceuticals, Inc. | 8.704B |
| Oncolytics Biotech, Inc. | 53.05M |
| Sangamo Therapeutics, Inc. | 48.47M |
| Sarepta Therapeutics, Inc. | 2.007B |
Market Cap Related Metrics
| Price to Book Value | 1.035 |
| Price | 0.65 |
| Earnings Yield | -58.91% |